Over 4,000 women in the U.S. die from cervical cancer each year. Learn why adoptive T-cell therapy is promising for metastic cervical cancer. . .
Hepatocellular carcinoma (HCC) is the most common form of liver cancer, accounting for up to 90 percent of cases, and is the second most common cause of cancer-related deaths worldwide according to the World Health Organization’s 2014 World Cancer Report. Learn more about how activated hepatic stellate cells alter the liver microenvironment to promote the recurrence of cancer . . .
If you are interested in interviewing a CCR scientist, OR you are a scientist who has been contacted by a member of the media, please contact the NCI Media Relations Branch at firstname.lastname@example.org or by phone at 301-496-6641.
Scientists at Work
Combination antiretroviral therapy (cART), which can completely block viral replication, is now used to control HIV in millions of patients worldwide. However, during infection, a DNA copy of the HIV genome is inserted into the cells it infects, which persists as long as the host cell lives, and can initiate an active infection if therapy is discontinued. This makes curing HIV a daunting task. Read more . . .
Among the most aggressive breast cancers are those that lack the estrogen receptor alpha (ER-), and have a “basal-like” gene expression signature. It was demonstrated that these ER- cancers frequently overexpress inducible nitric oxide synthase 2 (NOS2) which induces a basal-like gene expression pattern and also associates with poor patient survival. It was hypothesized that NOS2 may play an important causal role in the progression of ER- cancers. Read more . . .